Related references
Note: Only part of the references are listed.Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J. Joseph et al.
CIRCULATION (2022)
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Jennifer R. Kramer et al.
HEPATOLOGY (2022)
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease
Xinrong Zhang et al.
HEPATOLOGY (2022)
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study
Mary J. Thomson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
Huapeng Lin et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2022)
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD)
Danielle Brandman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes
Tracey G. Simon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world
Linda Henry et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives
Cheng Han Ng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analyses
Mengshi Yi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
Pioglitazone and bariatric surgery are the most effective treatments for non-alcoholic steatohepatitis: A hierarchical network meta-analysis
Simona Panunzi et al.
DIABETES OBESITY & METABOLISM (2021)
Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement
Hannes Hagstrom et al.
HEPATOLOGY (2021)
Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes
Stefano Ciardullo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Giovanni Targher et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
Fu-Shun Yen et al.
BMC GASTROENTEROLOGY (2021)
Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin
Saad Saffo et al.
DIABETES OBESITY & METABOLISM (2021)
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
Li Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Type 2 diabetes mellitus in older adults: clinical considerations and management
Srikanth Bellary et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Long-Term Complications in Youth-Onset Type 2 Diabetes
Petter Bjornstad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Trends in Diabetes Treatment and Control in US Adults, 1999-2018
Michael Fang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory-Wide Cohort Study
Xinrong Zhang et al.
HEPATOLOGY COMMUNICATIONS (2021)
Impact of first wave of COVID-19 on outcomes of hospitalization for upper gastrointestinal bleeding in Hong Kong: a population-based study
Thomas K. L. Lui et al.
ENDOSCOPY INTERNATIONAL OPEN (2021)
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
Stanley Khoo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETES CARE (2020)
Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes
Anjali Gopalan et al.
DIABETES CARE (2020)
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2020 EXECUTIVE SUMMARY
Alan J. Garber et al.
ENDOCRINE PRACTICE (2020)
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study
Hye Won Lee et al.
HEPATOLOGY (2020)
SGLT2 Inhibitors in Liver Patients
John Chen Hsiang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016
Catherine G. Derington et al.
HYPERTENSION (2020)
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B
Terry Cheuk-Fung Yip et al.
JOURNAL OF VIRAL HEPATITIS (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A3-year follow-up of the Qatar study
Muhammad Abdul-Ghani et al.
DIABETES OBESITY & METABOLISM (2020)
Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016
Daniel Santos et al.
JAMA NEUROLOGY (2020)
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
Paul Muntner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
Karl Bjorkstrom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Eduardo Vilar-Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016
Pooyan Kazemian et al.
JAMA INTERNAL MEDICINE (2019)
Trends in medication utilization, glycemic control and outcomes among type 2 diabetes patients in a tertiary referral center in Singapore from 2007 to 2017
Yan Zhi Tan et al.
JOURNAL OF DIABETES (2019)
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
Fernando Bril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Adherence to medication, glycaemic control and hospital attendance in young adults with type 2 diabetes
Shalini Kunasegaran et al.
INTERNAL MEDICINE JOURNAL (2018)
Type 2 diabetes in adolescents and young adults
Nadia Lascar et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017
Samantha Wilkinson et al.
BMJ OPEN (2018)
Lipid management in patients with chronic kidney disease
Charles J. Ferro et al.
NATURE REVIEWS NEPHROLOGY (2018)
Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
Ivy H. Y. Ng et al.
ENDOCRINOLOGY AND METABOLISM (2018)
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013
Kasia J. Lipska et al.
DIABETES CARE (2017)
New trends on obesity and NAFLD in Asia
Jian-Gao Fan et al.
JOURNAL OF HEPATOLOGY (2017)
Education achievement and type 2 diabetes-what mediates the relationship in older adults? Data from the ESTHER study: a population-based cohort study
Christopher J. Steele et al.
BMJ OPEN (2017)
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
Matthias Pinter et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population
T. C. -F. Yip et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia
Pierre Blais et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Continuation of Metformin Use After a Diagnosis of Cirrhosis Significantly Improves Survival of Patients With Diabetes
Xiaodan Zhang et al.
HEPATOLOGY (2014)
Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes A cross-sectional observational study from the AMD Annals initiative
Maria Chiara Rossi et al.
DIABETES CARE (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Achievement of Goals in U.S. Diabetes Care, 1999-2010
Mohammed K. Ali et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension The National Health and Nutrition Examination Survey, 2001 to 2010
Qiuping Gu et al.
CIRCULATION (2012)
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
Paul Muntner et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes
DJ Wexler et al.
DIABETES CARE (2005)
Share Paper
